NEWS
ONLY ONE IN 10 EUROPEAN HOSPITALS ARE ADEQUATELY PROTECTED AGAINST PHISHING
A new survey of European-based clinics and hospitals has revealed less than one in 10 institutions have correctly implemented basic phishing and spoofing protection .
The new research by EasyDMARC revealed the security policies of 2,000 clinics and hospitals based in Europe . It found that only 144 – or 7.2 % of the researched 2,000 facilities – have correctly implemented and configured security policies to flag , report and remove outbound phishing emails .
EasyDMARC ’ s research found that only 32 % of the reviewed domains had implemented the decade-old DMARC standard , of those institutions , only 144 ( 7.2 %) had implemented a ‘ reject ’ policy that automatically rejects emails imitating a legitimate domain . More organisations that deployed DMARC had configured it to do nothing about impersonating emails , with 361 ( 18 %) domains having no policy .
Gerasim Hovhannisyan , CEO and Co-founder , EasyDMARC , said : “ Impersonating email domains is one of the most effective ways cybercriminals bypass organisational cyberdefences through phishing , spoofing and ransomware attacks . Far too many organisations are overlooking a vital tool in effectively preventing this present and persistent danger .”
The survey reviewed the deployment of the Domain-based Message Authentication , Reporting and Conformance ( DMARC ) standard among European healthcare domains . First published in 2012 , the DMARC standard enables the automatic flagging and removal of receiving emails which are impersonating senders ’ domains , which is a crucial way to prevent outbound phishing and spoofing attempts .
AI-POWERED SKIN ANALYTICS WINS £ 2.1M NHS GRANT TO REVOLUTIONISE SKIN CANCER DETECTION
DigitalHealth . London Accelerator alumnus company , Skin Analytics , has been awarded £ 2,157,038 by the NHS Cancer Programme – supported by SBRI Healthcare and the Accelerated Access Collaborative – for their Class II UKCA-Certified Artificial Intelligence Medical
Device that streamlines the assessment process of skin lesions where there is a suspicion of skin cancer .
Skin Analytics works with the NHS to provide dermatology solutions that utilise Artificial Intelligence ( AI ) technology . Their innovative AI tool , DERM ( Deep Ensemble for the Recognition of Malignancy ), is capable of identifying 11 distinct types of skin lesions . This includes both malignant and premalignant lesions that can be treated if detected early , as well as benign lesions that may be discharged or monitored further .
By leveraging DERM , patients can be efficiently triaged prior to an in-person dermatology consultation , eliminating unnecessary hospital appointments for both patients and physicians . This system also enables local dermatologists to remotely review referred cases , allowing them to provide patients with the most optimal assessment and treatment options available .
Their award from the NHS Cancer Programme , in partnership with SBRI Healthcare and the Accelerated Access Collaborative , is part of a larger sum of £ 12.1 million which was granted to a total of six innovations that improve the early detection and diagnosis of cancer . The funding , spanning over 18 months , will help translate the latest research and innovation into practical use within front-line settings , improving overall patient outcomes .
www . intelligenthealth . tech 9